MedTrace Logo

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

NCT02374814 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-06-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.

Conditions

  • Rabies

Interventions

DRUG

Rabies vaccine

Compare dose schedule and route of administration

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Walter Reed Army Institute of Research (WRAIR)

    collaborator FED

  • State University of New York - Upstate Medical University

    lead OTHER

Principal Investigators

  • Mark Polhemus, MD · State University of New York - Upstate Medical University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-24
Primary Completion
2016-09-22
Completion
2016-09-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374814 on ClinicalTrials.gov